2006D-0383 | Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases | |||||||||||||||||||||||
FDA Comment Number : | EC3369 | |||||||||||||||||||||||
Submitter : | Mrs. Rosellyn Giampietro | Date & Time: | 12/15/2006 08:12:57 | |||||||||||||||||||||
Organization : | Mrs. Rosellyn Giampietro | |||||||||||||||||||||||
Category : | Individual Consumer | |||||||||||||||||||||||
Issue Areas/Comments | ||||||||||||||||||||||||
GENERAL | ||||||||||||||||||||||||
GENERAL | ||||||||||||||||||||||||
I am opposed to allowing pharmaceutical companies to develop new vaccines using aborted fetal cell lines. | ||||||||||||||||||||||||